Type-specific HPV and Pap test results among low-income, underserved women: Providing insights into management strategies

American Journal of Obstetrics and Gynecology

Volumn 211, Issue 4, 2014, Pages 354.e1-354.e6

  Saraiya, Mona ^a   Benard, Vicki B ^a   Greek, April A ^c   Steinau, Martin ^b   Patel, Sonya ^a   Massad, L Stewart ^d   Sawaya, George F ^e   Unger, Elizabeth R ^b  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c BATTELLE MEMORIAL INSTITUTE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cotesting; genotying; HPV testing; Pap test; underserved Populations

Indexed keywords

EID: 84907692172     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2014.05.001     Document Type: Article

References (22)

1. American College of Obstetricians and Gynecologists Cervical cytology screening. ACOG practice bulletin no. 45, August 2003. Clinical management guidelines for obstetrician-gynecologists Obstet Gynecol 102 2003 417 427
2. D. Saslow, C.D. Runowicz, and D. Solomon American Cancer Society guideline for the early detection of cervical neoplasia and cancer CA Cancer J Clin 52 2002 342 362
3. V.A. Moyer Screening for cervical cancer: US Preventive Services Task Force recommendation statement Ann Intern Med 156 2012 880 891 W312
4. American College of Obstetricians and Gynecologists Bulletins - Gynecology. ACOG Practice Bulletin no. 109: Cervical cytology screening Obstet Gynecol 114 2009 1409 1420
5. D. Saslow, D. Solomon, and H.W. Lawson American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the prevention and early detection of cervical cancer J Low Genit Tract Dis 16 2012 175 204
6. K.B. Roland, A. Soman, V.B. Benard, and M. Saraiya Human papillomavirus and Papanicolaou tests screening interval recommendations in the United States Am J Obstet Gyn 205 2011 441 448
7. K.R. Yabroff, M. Saraiya, and H.I. Meissner Specialty differences in primary care physician reports of papanicolaou test screening practices: a national survey, 2006 to 2007 Ann IntMed 151 2009 602 611
8. N.A. Hawkins, V.B. Benard, A. Greek, K.B. Roland, D. Manninen, and M. Saraiya Patient knowledge and beliefs as barriers to extending cervical cancer screening intervals in Federally Qualified Health Centers Prev Med 57 2013 641 645
9. K.B. Roland, V.B. Benard, A. Greek, N.A. Hawkins, D. Manninen, and M. Saraiya Primary care provider practices and beliefs related to cervical cancer screening with the HPV test in Federally Qualified Health Centers Prev Med 57 2013 419 425
10. H.A. Katki, W.K. Kinney, and B. Fetterman Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice Lancet Oncol 12 2011 663 672
11. T.C. Wright Jr., L.S. Massad, C.J. Dunton, M. Spitzer, E.J. Wilkinson, and D. Solomon 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests Am J Obstet Gynecol 197 2007 346 355
12. L.S. Massad, M.H. Einstein, and W.K. Huh 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors Obstet Gynecol 121 2013 829 846
13. P.E. Castle, B. Fetterman, N. Poitras, T. Lorey, R. Shaber, and W. Kinney Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting Obstet Gynecol 113 2009 595 600
14. What are federally qualified health centers (FQHCs)? US Department of Health and Human Services. Health Information Technology. Washington, DC: HRSA. Available at: http://www.hrsa.gov/healthit/toolbox/ruralhealthittoolbox/introduction/qualified.html. Accessed June 10, 2013.
15. V.B. Benard, M. Saraiya, and A. Greek Overview of the CDC Cervical Cancer (Cx3) Study: an educational intervention of HPV testing for cervical cancer screening J Women's Health 23 2014 197 203
16. D. Solomon, D. Davey, and R. Kurman The 2001 Bethesda System: terminology for reporting results of cervical cytology JAMA 287 2002 2114 2119
17. J.M. Onyekwuluje, M. Steinau, D.C. Swan, and E.R. Unger A real-time PCR assay for HPV52 detection and viral load quantification Clin Lab 58 2012 61 66
18. StataCorp. College Station, TX. Available at: http://www.stata.com. Accessed June 10, 2013.
19. H.A. Katki, M. Schiffman, and P.E. Castle Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines J Low Genit Tract Dis 17 Suppl 1 2013 S28 S35
20. T.C. Wright Jr., M.H. Stoler, C.M. Behrens, R. Apple, T. Derion, and T.L. Wright The ATHENA human papillomavirus study: design, methods, and baseline results Am J Obstet Gynecol 206 2012 46.e1 46.e11
21. Vesco KK Whitlock EPE, Eder M, et al. A Systematic Evidence Review for the US Preventive Services Task Force. Screen Cerv Cancer 2011; Evidence Syntheses, no. 86. Available at: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0016542/. Accessed June 10, 2013.
22. Ryerson AB, Benard VB, Majors A. National Breast and Cervical Cancer Early Detection Program: Summarizing the first 12 years of parnterships and progress against breast and cervical cancer. 2003. Available at: http://www.cdc.gov/cancer/nbccedp/data/. Accessed June 10, 2013.